Trials / Not Yet Recruiting
Not Yet RecruitingNCT07519577
A Study of CM512 in Patients With Chronic Rhinosinusitis With Nasal Polyposis （NEZHA-2）
An Open-Label, Single-Arm, Multicenter, Expansion Study to Evaluate the Safety and Efficacy of CM512 in Patients With Chronic Rhinosinusitis With Nasal Polyposis
- Status
- Not Yet Recruiting
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 120 (estimated)
- Sponsor
- Keymed Biosciences Co.Ltd · Industry
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
This is an open-label, single-arm, multicenter, expansion study to evaluate the safety and efficacy of CM512 in patients With Chronic Rhinosinusitis with Nasal Polyposis
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | CM512 | Administered subcutaneous injection |
Timeline
- Start date
- 2026-05-31
- Primary completion
- 2028-05-31
- Completion
- 2028-05-31
- First posted
- 2026-04-09
- Last updated
- 2026-04-09
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT07519577. Inclusion in this directory is not an endorsement.